scholarly article | Q13442814 |
P50 | author | Philip McGuire | Q37834611 |
Sagnik Bhattacharyya | Q43272523 | ||
Elizabeth Appiah-Kusi | Q57614927 | ||
Natalia Petros | Q92796974 | ||
P2093 | author name string | Michael Brammer | |
Jesus Perez | |||
Paul Allen | |||
Robin Wilson | |||
Matthijs G Bossong | |||
P2860 | cites work | Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology | Q24602238 |
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia | Q24607361 | ||
Translating the MAM model of psychosis to humans | Q26860217 | ||
Dissociable intrinsic connectivity networks for salience processing and executive control | Q28290658 | ||
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide | Q28362078 | ||
A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks | Q29619139 | ||
Saliency, switching, attention and control: a network model of insula function | Q29619521 | ||
Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis | Q30387810 | ||
Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis | Q30390106 | ||
Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies | Q31107763 | ||
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia | Q33963430 | ||
Systematic meta-analysis of insula volume in schizophrenia | Q34279283 | ||
Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. | Q34295212 | ||
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment | Q34304341 | ||
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States | Q34475129 | ||
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study | Q36928703 | ||
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia | Q36945634 | ||
The nature of dopamine dysfunction in schizophrenia and what this means for treatment | Q37062793 | ||
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis | Q37228333 | ||
Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic Symptoms | Q37430456 | ||
Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis. | Q37563725 | ||
A review of reward processing and motivational impairment in schizophrenia | Q37602601 | ||
Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver | Q37665156 | ||
Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study | Q37711762 | ||
Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction | Q37892677 | ||
Dopaminergic basis of salience dysregulation in psychosis | Q38175606 | ||
Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia | Q38466601 | ||
Dopamine reward prediction-error signalling: a two-component response | Q38728913 | ||
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor | Q38848638 | ||
Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-Analysis | Q40332969 | ||
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. | Q42519170 | ||
Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia | Q45027787 | ||
Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis | Q45758350 | ||
Altered activation and connectivity in a hippocampal-basal ganglia-midbrain circuit during salience processing in subjects at ultra high risk for psychosis | Q45839278 | ||
Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release | Q46182958 | ||
Modulation of motivational salience processing during the early stages of psychosis | Q47649698 | ||
Cortical salience network activation precedes the development of delusion severity | Q47980947 | ||
Alterations of the brain reward system in antipsychotic naïve schizophrenia patients | Q48002568 | ||
Motivation and movement: the effect of monetary incentive on performance speed | Q48152477 | ||
Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia. | Q48439772 | ||
Salience processing and insular cortical function and dysfunction | Q48453343 | ||
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. | Q48481384 | ||
Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. | Q49061063 | ||
Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis | Q49126675 | ||
FMRI visualization of brain activity during a monetary incentive delay task. | Q52167219 | ||
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. | Q52750107 | ||
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis | Q57403237 | ||
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task. | Q60630987 | ||
Dysconnectivity of Large-Scale Functional Networks in Early Psychosis: A Meta-analysis | Q60640855 | ||
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial | Q88271142 | ||
Prolonged Psychosis Associated with Left Insular Stroke: Talking to God in the Walls | Q88644336 | ||
P433 | issue | 1 | |
P921 | main subject | psychosis | Q170082 |
P304 | page(s) | 203 | |
P577 | publication date | 2019-08-22 | |
P1433 | published in | Translational Psychiatry | Q15716636 |
P1476 | title | Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis | |
P478 | volume | 9 |
Search more.